Among the different CardioVascular (CV) manifestation of the COronaVIrus-related Disease (COVID) particular attention has been paid to arrhythmia and particularly to Atrial fibrillation (AF). The aim of our study was to assess the incidence of AF episodes in patients ospitalisat for COVID and to evaluate its predictors and its relationship with in-hospital all-cause mortality.
Maloberti, A., Giannattasio, C., Rebora, P., Occhino, G., Ughi, N., Rizzo, J., et al. (2022). Atrial Fibrillation Incidence in SARS-COV-2 Infected Patients: Predictors and Relationship with in-Hospital Mortality. Intervento presentato a: 31st Annual Scientific Meeting of the European-Society-of-Hypertension (ESH) on Hypertension and Cardiovascular Protection - JUN 17-20, 2022, Athens, GREECE [10.1097/01.hjh.0000835888.39220.39].
Atrial Fibrillation Incidence in SARS-COV-2 Infected Patients: Predictors and Relationship with in-Hospital Mortality
Maloberti, Alessandro;Giannattasio, Cristina;Rebora, Paola;Occhino, Giuseppe;Fabbri, Saverio;Leidi, Filippo;Cartella, Iside;Bonfanti, Paolo;Valsecchi, Maria Grazia;Genovesi, Simonetta
2022
Abstract
Among the different CardioVascular (CV) manifestation of the COronaVIrus-related Disease (COVID) particular attention has been paid to arrhythmia and particularly to Atrial fibrillation (AF). The aim of our study was to assess the incidence of AF episodes in patients ospitalisat for COVID and to evaluate its predictors and its relationship with in-hospital all-cause mortality.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
